NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT00784953 ·Status: COMPLETED

Local Phase 4 Pan-European SMART Study

NCT00463866 ·Status: COMPLETED ·Phase: PHASE4

A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice

NCT00505388 ·Status: COMPLETED

Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)

NCT00937066 ·Status: COMPLETED

Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

NCT00576316 ·Status: COMPLETED ·Phase: PHASE4

Symbicort SMART Satisfaction From Patient Perspective 2009

NCT00946452 ·Status: COMPLETED

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

NCT00812357 ·Status: COMPLETED

Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler

NCT00524641 ·Status: COMPLETED

A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

NCT00503061 ·Status: COMPLETED

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT01647646 ·Status: COMPLETED ·Phase: PHASE4

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day

NCT01360021 ·Status: COMPLETED ·Phase: PHASE3

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

NCT00259792 ·Status: COMPLETED ·Phase: PHASE3

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Efficacy of Symbicort® SMART.

NCT00839800 ·Status: COMPLETED ·Phase: PHASE3

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

NCT00858286 ·Status: COMPLETED ·Phase: PHASE4

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

NCT00319306 ·Status: COMPLETED ·Phase: PHASE3

Effect of Symbicort on GR Localisation in Asthma

NCT00159263 ·Status: COMPLETED ·Phase: NA

SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma

NCT00290264 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

NCT00646321 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

NCT00652392 ·Status: COMPLETED ·Phase: PHASE3

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

NCT01444430 ·Status: COMPLETED ·Phase: PHASE3

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

NCT00658255 ·Status: COMPLETED ·Phase: PHASE2

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

NCT00238784 ·Status: COMPLETED ·Phase: PHASE3

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 ·Status: COMPLETED ·Phase: PHASE4

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

NCT01711840 ·Status: COMPLETED